Cengel, Keith A <br/><br/>
C225 and PDT combination therapy for ovarian cancer: the play's the thing.  [electronic resource] 

 -  Journal of the National Cancer Institute  Oct 2005 
 - 1488-9 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/dji360  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--pharmacology<br/>Carcinoma--drug therapy<br/>Cetuximab<br/>Drug Synergism<br/>ErbB Receptors--drug effects<br/>Female<br/>Hematoporphyrin Photoradiation--methods<br/>Immunotherapy--methods<br/>Injections, Intraperitoneal<br/>Low-Level Light Therapy--methods<br/>Mice<br/>Ovarian Neoplasms--drug therapy<br/>Peritoneal Neoplasms--drug therapy<br/>Photosensitizing Agents--pharmacology<br/>Porphyrins--pharmacology<br/>Transplantation, Heterologous<br/>Tumor Cells, Cultured